Second quarter net sales of $1.942 billion increased 3.9% and 5.
6% on a constant currency 1 basis Second quarter diluted earnings per share were $1.18 ; adjusted 1 diluted earnings per share were $2.01 The Company updates 2024 reported revenue guidance due to currency expectations and reaffirms 2024 constant currency revenue growth and adjusted 1 earnings per share financial guidance WARSAW, Ind.
, Aug. 7, 2024 /PRNewswire/ -- Zimmer Biomet Holdings, Inc. (NYSE and SIX: ZBH) today reported financial results for the quarter ended June 30, 2024.
The Company reported second quarter net sales of $1.942 billion , an increase of 3.9% over the prior year period, and an increase of 5.
6% on a constant currency 1 basis. Net earnings for the second quarter were $242.8 million , or $415.
0 million on an adjusted 1 basis. Diluted earnings per share were $1.18 for the second quarter, and adjusted 1 diluted earnings per share were $2.
01 . "We delivered a strong Q2 – beating our expectations on both the top and bottom line, driven by customer demand for our suite of diversified products and solutions, as well as the strength and breadth of our international business," said Ivan Tornos, Zimmer Biomet's President and Chief Executive Officer. "Our performance demonstrates the progress we are making against our key priorities that support our long-range plan – people and culture, operational excellence, and innovation and diversification.
" Recent Highlights Announced the signing of a definiti.